Webinar : Detecting Alzheimer’s disease subtypes with serum proteomics

We are pleased to announce an upcoming webinar in collaboration with Olink, Part of Thermo Fisher, titled “Detecting Alzheimer’s Disease Subtypes with Serum Proteomics”, showcasing how advanced proteomic technologies are reshaping our understanding of Alzheimer’s disease.

Neurological disease research is evolving rapidly, with proteomics offering new insights into disease mechanisms and heterogeneity. This webinar will explore recent advances in CSF and serum proteomics to identify distinct molecular subtypes of Alzheimer’s disease.